Have a personal or library account? Click to login
Identifying obstetrics patients in whom RHD genotyping can be used to assess risk of D alloimmunization Cover

Identifying obstetrics patients in whom RHD genotyping can be used to assess risk of D alloimmunization

Immunohematology
Volume 36 (2020): Issue 4 (December 2020)
By: T.N. Horn,  J. Keller,  M.A. Keller and  L. Klinger  
Paid access
|Jan 2020

Full Article

Cover

Access required

This content requires purchase or subscription access to view the full article.

DOI: https://doi.org/10.21307/immunohematology-2020-054 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 146 - 151
Published on: Jan 1, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
D,
blood group antigen,
genotyping,
pregnancy,
alloimmunization,
RhIG prophylaxis,
hemolytic disease of fetus and newborn (HDFN)
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2020 T.N. Horn, J. Keller, M.A. Keller, L. Klinger, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 36 (2020): Issue 4 (December 2020)Next article